• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫细胞检测法是膀胱癌患者随访方案中的一种有用方法。

ImmunoCyt a useful method in the follow-up protocol for patients with urinary bladder carcinoma.

作者信息

Olsson H, Zackrisson B

机构信息

Department of Clinical Pathology, Borås Central Hospital, Sweden.

出版信息

Scand J Urol Nephrol. 2001 Sep;35(4):280-2. doi: 10.1080/003655901750425846.

DOI:10.1080/003655901750425846
PMID:11676352
Abstract

OBJECTIVE

To evaluate the ImmunoCyt test--a urine-bound test for the detection of malignant transitional cells.

PATIENTS AND METHODS

ImmunoCyt was compared with the standard investigation at our hospital for bladder cancer--cystoscopy, cytological examination of bladder wash material and, if necessary, a histological examination. A voided urine sample was collected before cystoscopy. We investigated 121 patients; seven specimens could not be evaluated.

RESULTS

Thirty-one of the 114 patients had a histologically proven urinary bladder carcinoma. All 31 cases were positive in the ImmunoCyt test. Twenty-six of the 83 negative cases were ImmunoCyt positive. The sensitivity was 100% and the specificity was 68.7%.

CONCLUSION

ImmunoCyt is easily applicable in a small laboratory and has high sensitivity and acceptable specificity.

摘要

目的

评估免疫细胞检测法——一种用于检测恶性移行细胞的尿液检测方法。

患者与方法

将免疫细胞检测法与我院膀胱癌的标准检查方法——膀胱镜检查、膀胱冲洗液细胞学检查以及必要时的组织学检查进行比较。在膀胱镜检查前收集一份晨尿样本。我们对121例患者进行了研究;7份标本无法进行评估。

结果

114例患者中有31例经组织学证实患有膀胱癌。所有31例在免疫细胞检测中均为阳性。83例阴性病例中有26例免疫细胞检测呈阳性。敏感性为100%,特异性为68.7%。

结论

免疫细胞检测法易于在小型实验室应用,具有高敏感性和可接受的特异性。

相似文献

1
ImmunoCyt a useful method in the follow-up protocol for patients with urinary bladder carcinoma.免疫细胞检测法是膀胱癌患者随访方案中的一种有用方法。
Scand J Urol Nephrol. 2001 Sep;35(4):280-2. doi: 10.1080/003655901750425846.
2
Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.免疫细胞检测提高了尿液细胞学检查的诊断准确性:一项法国多中心研究的结果。
J Urol. 2003 Mar;169(3):921-4. doi: 10.1097/01.ju.0000048983.83079.4c.
3
Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.免疫细胞检测法在膀胱移行细胞癌诊断中的准确性。
Anticancer Res. 2003 Mar-Apr;23(2A):963-7.
4
Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence.免疫细胞检测对浅表性膀胱癌复发的诊断效能
Urology. 2001 Sep;58(3):367-71. doi: 10.1016/s0090-4295(01)01217-1.
5
[ImmunoCyt--a new urine test in diagnosis of bladder cancer].免疫细胞检测——一种用于膀胱癌诊断的新型尿液检测方法
Urologe A. 2003 Apr;42(4):531-7. doi: 10.1007/s00120-002-0253-8. Epub 2003 Jan 17.
6
Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.免疫细胞检测和HA-HAase尿液检测用于膀胱癌检测:并列比较
Eur Urol. 2004 Oct;46(4):466-71. doi: 10.1016/j.eururo.2004.06.006.
7
uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma: an update on 7422 analyses.uCyt+/ImmunoCyt 与细胞学在尿路上皮癌检测中的应用:7422 例分析更新。
Cancer Cytopathol. 2013 Jul;121(7):392-7. doi: 10.1002/cncy.21287. Epub 2013 Mar 12.
8
Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.评估DD23作为膀胱癌病史患者复发性膀胱移行细胞癌检测标志物的价值。
Urology. 2003 Mar;61(3):539-43. doi: 10.1016/s0090-4295(02)02400-7.
9
Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report.免疫细胞化学检测上尿路移行细胞癌:初步报告
Urology. 2001 Sep;58(3):362-6. doi: 10.1016/s0090-4295(01)01182-7.
10
[Clinical usefulness of the ImmunoCyt urinary test in the follow-up protocol of patients with urothelial neoplasms].[免疫细胞尿检测在尿路上皮肿瘤患者随访方案中的临床应用价值]
Actas Urol Esp. 2005 Jun;29(6):535-41. doi: 10.1016/s0210-4806(05)73293-9.

引用本文的文献

1
Review of non-invasive urinary biomarkers in bladder cancer.膀胱癌非侵入性尿液生物标志物综述。
Transl Cancer Res. 2020 Oct;9(10):6554-6564. doi: 10.21037/tcr-20-1990.
2
Current Use and Promise of Urinary Markers for Urothelial Cancer.尿路上皮癌尿液标志物的当前应用与前景
Curr Urol Rep. 2018 Oct 17;19(12):96. doi: 10.1007/s11934-018-0857-1.
3
MtDNA As a Cancer Marker: A Finally Closed Chapter?线粒体DNA作为一种癌症标志物:终于画上句号了吗?
Curr Genomics. 2017 Jun;18(3):255-267. doi: 10.2174/1389202918666170105093635.
4
Urothelial Bladder Cancer Urinary Biomarkers.尿路上皮膀胱癌的尿液生物标志物
EJIFCC. 2014 Apr 28;25(1):99-114. eCollection 2014 Apr.
5
New and contemporary markers of prognosis in nonmuscle invasive urothelial cancer.非肌层浸润性尿路上皮癌新的及当代预后标志物
Korean J Urol. 2015 Aug;56(8):553-64. doi: 10.4111/kju.2015.56.8.553. Epub 2015 Jul 31.
6
Bladder cancer screening in aluminum smelter workers.铝冶炼工人的膀胱癌筛查
J Occup Environ Med. 2015 Apr;57(4):421-7. doi: 10.1097/JOM.0000000000000377.
7
Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement.接触膀胱致癌物工人的医学随访:法国循证务实声明
BMC Public Health. 2014 Nov 6;14:1155. doi: 10.1186/1471-2458-14-1155.
8
Urinary markers for bladder cancer.膀胱癌的尿液标志物。
F1000Prime Rep. 2013 Jul 1;5:21. doi: 10.12703/P5-21. Print 2013.
9
[Urine marker systems for diagnosis of urothelial cancer].[用于诊断尿路上皮癌的尿液标志物系统]
Urologe A. 2013 Jul;52(7):965-9. doi: 10.1007/s00120-013-3227-0.
10
Urine cytology and adjunct markers for detection and surveillance of bladder cancer.用于膀胱癌检测和监测的尿液细胞学及辅助标志物。
Am J Transl Res. 2010 Jul 25;2(4):412-40.